Apyx Medical
APYX
67 hedge funds and large institutions have $63.5M invested in Apyx Medical in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 9 closing their positions.
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
1.62% less ownership
Funds ownership: 53.42% → 51.8% (-1.6%)
3% less funds holding
Funds holding: 69 → 67 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
59% less capital invested
Capital invested by funds: $154M → $63.5M (-$90.9M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$864K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$803K |
| 3 |
CAC
Cowen and Company
New York
|
+$798K |
| 4 |
JP Morgan Chase
New York
|
+$721K |
| 5 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
+$447K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
-$1.89M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.67M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
-$1.16M |
| 4 |
Goldman Sachs
New York
|
-$1.16M |
| 5 |
RA
Royce & Associates
New York
|
-$811K |
APYX Hedge Fund Activity: Q1 2020 in Review
67 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2020, worth a combined $63.5M — down 59% from $154M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of APYX and 8 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 21 added.
The largest buyer was Pura Vida Investments, adding an estimated $864K. The largest seller was Silvercrest Asset Management, cutting an estimated $1.89M.
- 67 institutional investors held Apyx Medical (APYX) as of Q1 2020, down from 69 in Q4 2019.
- Funds reported $63.5M of Apyx Medical stock for Q1 2020, down 59% quarter-over-quarter.
- 8 funds opened new Apyx Medical positions in Q1 2020 and 9 closed out, a net change of -1 holder.
- The largest Apyx Medical buyer in Q1 2020 was Pura Vida Investments, an estimated $864K added.
- The largest Apyx Medical seller in Q1 2020 was Silvercrest Asset Management, an estimated $1.89M sold.
Based on aggregated 13F filings for Q1 2020.